Perceptions and attitudes regarding delayed antibiotic prescription for respiratory tract infections: a qualitative study.


Journal

BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676

Informations de publication

Date de publication:
04 10 2023
Historique:
received: 08 02 2023
accepted: 09 08 2023
medline: 1 11 2023
pubmed: 5 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

Antibiotics are overprescribed for respiratory tract infections (RTIs). However, the decision to prescribe is often complex. Delayed antibiotic prescription (DAP), a strategy designed to promote more rational antibiotic use, is still not widely used. The aim of this study was to explore perceptions and attitudes in primary care professionals, regarding antibiotic use and different DAP strategies for uncomplicated RTIs. We conducted a qualitative study, using an inductive thematic approach to generate themes, based on focus group discussions and semi-structured interviews with professionals, recruited from 6 primary care centres (Barcelona metropolitan area, Spain). 26 professionals (25 family physicians and one nurse) were included in four focus group discussions and three semi-structured interviews. Participants commented that RTIs were a main reason for consultation, motivated often by patient anxiety and fear of possible complications, and this was associated with the patients' poor health-related education. Acknowledging inappropriate antibiotic use in the health system, participants attributed this, mainly to defensive medicine strategies. DAP was used when in doubt about the aetiology, and considering factors related to patient-physician interactions. The main perceived advantage of DAP was that it could reduce the need for additional visits, while the main disadvantage was uncertainty regarding proper use by the patient. DAP was used by participants in cases of doubt, in specific situations, and for specific patient profiles. Weak points were detected in our primary care system and its users that affect the proper use of both antibiotics and DAP, namely, time pressure on professionals, poor patient health-related education, and the lack of a patient-physician relationship in some scenarios.

Sections du résumé

BACKGROUND
Antibiotics are overprescribed for respiratory tract infections (RTIs). However, the decision to prescribe is often complex. Delayed antibiotic prescription (DAP), a strategy designed to promote more rational antibiotic use, is still not widely used. The aim of this study was to explore perceptions and attitudes in primary care professionals, regarding antibiotic use and different DAP strategies for uncomplicated RTIs.
METHODS
We conducted a qualitative study, using an inductive thematic approach to generate themes, based on focus group discussions and semi-structured interviews with professionals, recruited from 6 primary care centres (Barcelona metropolitan area, Spain).
RESULTS
26 professionals (25 family physicians and one nurse) were included in four focus group discussions and three semi-structured interviews. Participants commented that RTIs were a main reason for consultation, motivated often by patient anxiety and fear of possible complications, and this was associated with the patients' poor health-related education. Acknowledging inappropriate antibiotic use in the health system, participants attributed this, mainly to defensive medicine strategies. DAP was used when in doubt about the aetiology, and considering factors related to patient-physician interactions. The main perceived advantage of DAP was that it could reduce the need for additional visits, while the main disadvantage was uncertainty regarding proper use by the patient.
CONCLUSIONS
DAP was used by participants in cases of doubt, in specific situations, and for specific patient profiles. Weak points were detected in our primary care system and its users that affect the proper use of both antibiotics and DAP, namely, time pressure on professionals, poor patient health-related education, and the lack of a patient-physician relationship in some scenarios.

Identifiants

pubmed: 37794330
doi: 10.1186/s12875-023-02123-4
pii: 10.1186/s12875-023-02123-4
pmc: PMC10548630
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

204

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

BMC Fam Pract. 2017 Feb 13;18(1):20
pubmed: 28193174
Med J Aust. 2017 Jul 17;207(2):65-69
pubmed: 28701117
Br J Gen Pract. 2011 Sep;61(590):e579-89
pubmed: 22152745
Lancet. 2005 Feb 12-18;365(9459):579-87
pubmed: 15708101
Bull World Health Organ. 2001;79(4):373-4
pubmed: 11357217
BMJ. 1997 Aug 9;315(7104):350-2
pubmed: 9270458
Cochrane Database Syst Rev. 2013 Nov 05;(11):CD000023
pubmed: 24190439
BMJ Open. 2016 Nov 18;6(11):e011882
pubmed: 27864242
BMJ. 2004 Feb 21;328(7437):444
pubmed: 14966079
J Fam Pract. 2002 Nov;51(11):954-9
pubmed: 12485551
Pediatrics. 2021 Mar;147(3):
pubmed: 33574163
Can Fam Physician. 2020 Sep;66(9):651-659
pubmed: 32933978
Br J Gen Pract. 2014 Dec;64(629):604-5
pubmed: 25452508
JAMA Intern Med. 2016 Jan;176(1):21-9
pubmed: 26719947
Gac Sanit. 2008 May-Jun;22(3):179-87
pubmed: 18579042
Fam Pract. 2020 Jul 23;37(3):406-411
pubmed: 31784735
Enferm Infecc Microbiol Clin. 2010 Apr;28(4):222-6
pubmed: 19720435
Scand J Prim Health Care. 2005 Jun;23(2):120-5
pubmed: 16036552
Br J Gen Pract. 2011 May;61(586):e252-61
pubmed: 21619749
Br J Gen Pract. 2010 Dec;60(581):907-12
pubmed: 21144201
J Int Med Res. 2018 Aug;46(8):3337-3357
pubmed: 29962311
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
BMJ Open. 2016 Oct 24;6(10):e012244
pubmed: 27798010
BMC Fam Pract. 2019 Mar 26;20(1):45
pubmed: 30914044
BMJ. 2021 Apr 28;373:n808
pubmed: 33910882

Auteurs

Gemma Mas-Dalmau (G)

Epidemiology and Public Health Department - Iberoamerican Cochrane Centre, Hospital de la Santa Creu i Sant Pau - Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain. gmasd@santpau.cat.
Nursing Care Research Group, IIB Sant Pau, Barcelona, Spain. gmasd@santpau.cat.

Sandra Pequeño-Saco (S)

Epidemiology and Public Health Department - Iberoamerican Cochrane Centre, Hospital de la Santa Creu i Sant Pau - Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
Sub- Directorate General of Surveillance and Response to Public Health Emergencies, Public Health Agency of Catalonia, Generalitat of Catalonia, Barcelona, Spain.

Mariam de la Poza-Abad (M)

Doctor Carles Ribas Primary Care Centre, Barcelona, Spain.

Eulàlia Borrell-Thió (E)

Sant Roc Primary Care Centre, Badalona, Spain.

Marta Besa-Castellà (M)

Florida Sud Primary Care Centre, Hospitalet de Llobregat, Barcelona, Spain.

Maria Alsina-Casalduero (M)

Llefià Primary Care Centre, Badalona, Spain.
PADES (Domestic Care Program, Support Teams) Mutuam Group, Barcelona, Spain.

Lluís Cuixart-Costa (L)

Roger de Flor Primary Care Centre, Barcelona, Spain.

Mercedes Liroz-Navarro (M)

Doctor Carles Ribas Primary Care Centre, Barcelona, Spain.

Carlos Calderón-Gómez (C)

Alza Primary Care Centre, San Sebastián, Spain.

Joel Martí (J)

Centre d'Estudis Sociològics sobre la Vida Quotidiana i el Treball (QUIT), Institut d'Estudis del Treball (IET), Universitat Autònoma de Barcelona, Bellaterra, Spain.

Irene Cruz-Gómez (I)

Centre d'Estudis Sociològics sobre la Vida Quotidiana i el Treball (QUIT), Institut d'Estudis del Treball (IET), Universitat Autònoma de Barcelona, Bellaterra, Spain.

Pablo Alonso-Coello (P)

Epidemiology and Public Health Department - Iberoamerican Cochrane Centre, Hospital de la Santa Creu i Sant Pau - Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
CIBER Epidemiology and Public Health, Instituto de Salud Carlos III (CIBERESP), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH